Our plain-English summary of Proceedings: Biological effects of asbestos. Unanswered questions posed by epidemiological studies, by J.C. Gilson (Clinical Science and Molecular Medicine, 1974).
You don't need the product names or old records. No fee unless we recover compensation for your family.
The study
- Author: J.C. Gilson
- Journal: Clinical Science and Molecular Medicine
- Published: 1974;47(3):11P
- Read it: PubMed · Publisher
In plain English
This item is a short abstract of a talk given at a Medical Research Society symposium on the biological effects of asbestos, held in Cardiff on 12 July 1974. It is not a study and reports no new data. The author, from the M.R.C. Pneumoconiosis Unit, gave an overview of epidemiological studies of past asbestos exposure reported from many countries over the previous 10 years. According to the author, those studies revealed material differences in the risk of asbestosis and asbestos-related cancers, linked to the type of asbestos, the section of the industry, dose of dust, time since first exposure, and smoking habits. The author listed unanswered questions. Are cancers other than pulmonary and mesothelial ones associated with asbestos? Is there excess bronchial cancer risk without asbestosis? If mesothelioma risk is highest with crocidolite and least with anthophyllite, where do chrysotile and amosite lie? Do risk differences relate to the chemical or physical properties of the fibres? Could widespread, increasing asbestos use cause a significant community hazard? The author suggested studying these factors in animals and in populations with contrasting exposures.
We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.
What the study did and found
- Design: Brief symposium abstract: an overview of other epidemiological studies and a list of open research questions, with no new data
- Who was studied: No study population. The abstract refers in general terms to epidemiological studies reported from many countries over the previous 10 years.
- Exposure: Past exposure to asbestos in general. Crocidolite, anthophyllite, chrysotile and amosite are named in the questions about mesothelioma risk.
- Main results:
- The author's account of earlier studies, not this item's own findings: those studies revealed material differences in the risk of developing asbestosis and asbestos-related cancers.
- According to the author, the factors identified in those studies were type of asbestos, section of the industry where exposure occurred, dose of dust, interval since first exposure, and smoking habits.
- Unanswered question listed by the author: whether cancers other than pulmonary and mesothelial cancers are associated with asbestos exposure.
- Unanswered question listed by the author: whether there is an excess bronchial cancer risk in the absence of asbestosis.
- Unanswered question listed by the author: whether differences in mesothelioma risk relate to chemical or physical properties of the fibres, and if physical, whether other fibres pose risks.
- Unanswered question listed by the author: whether widespread and increasing use of asbestos is likely to cause a significant community hazard.
- The authors' conclusion: The author stated that some of these factors can be studied experimentally in animals, and others by further epidemiological work in populations with contrasting exposures.
Topics
The National Library of Medicine indexes this study under subjects our site covers: Asbestosis.
Related studies
- Proceedings: The physicist's approach to asbestos cancers — V. Timbrell (1974)
- Historical state of knowledge of the health risks of asbestos posed to seamen on merchant ships — D.G. Dodge, B.D. Beck (2016)
- Medical Challenge Posed by Retroperitoneal Fibrosis: Case Reports and Literature Review — S. Cervera-Bonilla, M. Garcia Mora, et al. (2020)
- Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology Annual meeting, part 2: effusion cytology with focus on theranostics and diagnosis of malignant mesothelioma — M.T. Siddiqui, F. Schmitt, et al. (2019)
- Proceedings: Asbestos carcinogenesis — J.C. Wagner (1975)
- Proceedings of the 2017 National Toxicology Program Satellite Symposium — S.A. Elmore, F. Aeffner, et al. (2017)
Browse return to medical research.
How to cite it
Cite the study
J.C. Gilson. Proceedings: Biological effects of asbestos. Unanswered questions posed by epidemiological studies. Clinical Science and Molecular Medicine 1974;47(3):11P. doi:10.1042/cs047011pa. PMID: 4419326.
Cite our summary
“Proceedings: Biological effects of asbestos. Unanswered questions posed by epidemiological studies.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/proceedings-biological-effects-of-asbestos-unanswered-questions-posed.
ACL Doc numbers and their short links never change. See how to cite the Library.
Talk with an asbestos lawyer
Start with what you remember, and we'll take it from there.
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.